from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0791c/-

LFCtreatmentdescriptionclass of inhibitor

-0.459

Amikacinug/mL Amikacintranslation

-0.546

Cap5-10ug/mL Capreomycintranslation

-0.630

Rox10-50 ug/mL Roxithromycintranslation

0.841

SM2-5 ug/mL Streptomycintranslation

-1.233

Tet5-10 ug/mL Tetracyclinetranslation

-0.071

Rif0.2-5ug/mL Rifampicintranscription

-0.131

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.151

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.406

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.432

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.714

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.235

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.305

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.097

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.861

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.160

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.655

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.863

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.128

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.162

KCN5-20 ug/mL Potassium cyaniderespiration

0.439

NaN30.2-2 mM Sodium aziderespiration

-0.624

Nigericin50 uM Nigericinrespiration

-0.275

TRC10-150 ug/mL Triclosanrespiration

-0.215

TRZ10-25 ug/mL Thioridazinerespiration

-0.345

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.565

menadione6-10 ug/mL Menadionerespiration

-0.455

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.394

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.377

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.014

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.596

NRP_1Non-replicating persistence stage 1dosRassociated

-0.372

Amp0.2mg/mL AmpicillincellWall

-0.480

Cephalexin20-100 ug/mL CephalexincellWall

-0.271

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.264

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.575

EMB10-20 ug/mL EthambutolcellWall

-0.253

Eta12-40 ug/mL EthionamidecellWall

-0.635

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.437

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.403

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.054

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.935

BZA0.12 mg/mL BenzamidearomaticAmides

1.183

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

2.418

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.166

H2O24 mM hydrogen peroxideDNAdamaging

-0.521

Levo10 ug/mL LevofloxacinDNAdamaging

-0.364

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.099

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.607

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.325

UVUV-irradiationDNAdamaging

0.917

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.368

Antimycin12.5-50 ug/mL Antimycin A?

-0.446

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.127

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.121

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.622

PA8240.2-2 ug/mL PA-824?

-0.853

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.359

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.318

Verapamil50 uM Verapamil?

-0.575

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.227

methoxatin10-20 ug/mL Methoxatin?